Cargando…

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS

Detalles Bibliográficos
Autores principales: Sriphoosanaphan, Supachaya, Suksawatamnuay, Sirinporn, Srisoonthorn, Nunthiya, Siripon, Nipaporn, Thaimai, Panarat, Makhasen, Wanwisar, Mungnamtrakul, Nawakodchamon, Thanapirom, Kessarin, Nonthasoot, Bunthoon, Hansasuta, Pokrath, Komolmit, Piyawat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212357/
http://dx.doi.org/10.1016/S0016-5085(22)63690-4

Ejemplares similares